CSL Ltd
ASX:CSL
CSL Ltd
Net Change in Cash
CSL Ltd
Net Change in Cash Peer Comparison
Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors
Company | Net Change in Cash | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
CSL Ltd
ASX:CSL
|
Net Change in Cash
-$446.3m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-18%
|
CAGR 10-Years
-22%
|
|
Immutep Ltd
ASX:IMM
|
Net Change in Cash
AU$43.4m
|
CAGR 3-Years
8%
|
CAGR 5-Years
29%
|
CAGR 10-Years
21%
|
|
Mesoblast Ltd
ASX:MSB
|
Net Change in Cash
$9.9m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-20%
|
CAGR 10-Years
N/A
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Net Change in Cash
AU$44.9m
|
CAGR 3-Years
43%
|
CAGR 5-Years
25%
|
CAGR 10-Years
N/A
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Net Change in Cash
AU$6.9m
|
CAGR 3-Years
-41%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Net Change in Cash
AU$8.3m
|
CAGR 3-Years
33%
|
CAGR 5-Years
8%
|
CAGR 10-Years
23%
|
See Also
What is CSL Ltd's Net Change in Cash?
Net Change in Cash
-446.3m
USD
Based on the financial report for Dec 31, 2023, CSL Ltd's Net Change in Cash amounts to -446.3m USD.
What is CSL Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 10Y
-22%
Over the last year, the Net Change in Cash growth was 91%.